imidazo[1,2-f]phenanthridine

Shenyang Mole Pharmaceutical Technology Development, founded in 2007, supplies a wide range of nitrogen-heterocyclic chiral and fine-chemical intermediates — including substituted pyridines, bipyridines, triazines, phenanthrolines, and phenanthridine derivatives — to customers across North America, Europe, Asia, the Middle East, and Africa.